CHAPTER 1:INTRODUCTION
1.1.Report description
1.2.Key market segments
1.3.Key benefits to the stakeholders
1.4.Research Methodology
1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models
CHAPTER 2:EXECUTIVE SUMMARY
2.1.Key findings of the study
2.2.CXO Perspective
CHAPTER 3:MARKET OVERVIEW
3.1.Market definition and scope
3.2.Key findings
3.2.1.Top investment pockets
3.3.Porter’s five forces analysis
3.4.Top player positioning
3.5.Market dynamics
3.5.1.Drivers
3.5.2.Restraints
3.5.3.Opportunities
3.6.COVID-19 Impact Analysis on the market
CHAPTER 4: 3D CELL CULTURE MARKET, BY PRODUCT
4.1 Overview
4.1.1 Market size and forecast
4.2 Scaffold Based Platforms
4.2.1 Key market trends, growth factors and opportunities
4.2.2 Market size and forecast, by region
4.2.3 Market analysis by country
4.2.4 Scaffold Based Platforms 3D Cell Culture Market by Macro-scale
4.2.5 Scaffold Based Platforms 3D Cell Culture Market by Micro-scale
4.2.6 Scaffold Based Platforms 3D Cell Culture Market by Nano-scale
4.2.7 Scaffold Based Platforms 3D Cell Culture Market by Solid Scaffolds
4.3 Scaffold Free Platforms
4.3.1 Key market trends, growth factors and opportunities
4.3.2 Market size and forecast, by region
4.3.3 Market analysis by country
4.4 Gels
4.4.1 Key market trends, growth factors and opportunities
4.4.2 Market size and forecast, by region
4.4.3 Market analysis by country
4.5 Bioreactors
4.5.1 Key market trends, growth factors and opportunities
4.5.2 Market size and forecast, by region
4.5.3 Market analysis by country
4.6 Microchips
4.6.1 Key market trends, growth factors and opportunities
4.6.2 Market size and forecast, by region
4.6.3 Market analysis by country
4.7 Services
4.7.1 Key market trends, growth factors and opportunities
4.7.2 Market size and forecast, by region
4.7.3 Market analysis by country
CHAPTER 5: 3D CELL CULTURE MARKET, BY APPLICATION
5.1 Overview
5.1.1 Market size and forecast
5.2 Cancer Research
5.2.1 Key market trends, growth factors and opportunities
5.2.2 Market size and forecast, by region
5.2.3 Market analysis by country
5.3 Stem Cell Research
5.3.1 Key market trends, growth factors and opportunities
5.3.2 Market size and forecast, by region
5.3.3 Market analysis by country
5.4 Drug Discovery
5.4.1 Key market trends, growth factors and opportunities
5.4.2 Market size and forecast, by region
5.4.3 Market analysis by country
5.5 Regenerative medicine
5.5.1 Key market trends, growth factors and opportunities
5.5.2 Market size and forecast, by region
5.5.3 Market analysis by country
CHAPTER 6: 3D CELL CULTURE MARKET, BY END USER
6.1 Overview
6.1.1 Market size and forecast
6.2 Biotechnology and Pharmaceutical Companies
6.2.1 Key market trends, growth factors and opportunities
6.2.2 Market size and forecast, by region
6.2.3 Market analysis by country
6.3 Contract Research Laboratories
6.3.1 Key market trends, growth factors and opportunities
6.3.2 Market size and forecast, by region
6.3.3 Market analysis by country
6.4 Academic Institutes
6.4.1 Key market trends, growth factors and opportunities
6.4.2 Market size and forecast, by region
6.4.3 Market analysis by country
CHAPTER 7: 3D CELL CULTURE MARKET, BY REGION
7.1 Overview
7.1.1 Market size and forecast
7.2 North America
7.2.1 Key trends and opportunities
7.2.2 North America Market size and forecast, by Product
7.2.3 North America Market size and forecast, by Application
7.2.4 North America Market size and forecast, by End User
7.2.5 North America Market size and forecast, by country
7.2.5.1 U.S.
7.2.5.1.1 Market size and forecast, by Product
7.2.5.1.2 Market size and forecast, by Application
7.2.5.1.3 Market size and forecast, by End User
7.2.5.2 Canada
7.2.5.2.1 Market size and forecast, by Product
7.2.5.2.2 Market size and forecast, by Application
7.2.5.2.3 Market size and forecast, by End User
7.2.5.3 Mexico
7.2.5.3.1 Market size and forecast, by Product
7.2.5.3.2 Market size and forecast, by Application
7.2.5.3.3 Market size and forecast, by End User
7.3 Europe
7.3.1 Key trends and opportunities
7.3.2 Europe Market size and forecast, by Product
7.3.3 Europe Market size and forecast, by Application
7.3.4 Europe Market size and forecast, by End User
7.3.5 Europe Market size and forecast, by country
7.3.5.1 Germany
7.3.5.1.1 Market size and forecast, by Product
7.3.5.1.2 Market size and forecast, by Application
7.3.5.1.3 Market size and forecast, by End User
7.3.5.2 France
7.3.5.2.1 Market size and forecast, by Product
7.3.5.2.2 Market size and forecast, by Application
7.3.5.2.3 Market size and forecast, by End User
7.3.5.3 UK
7.3.5.3.1 Market size and forecast, by Product
7.3.5.3.2 Market size and forecast, by Application
7.3.5.3.3 Market size and forecast, by End User
7.3.5.4 Rest of Europe
7.3.5.4.1 Market size and forecast, by Product
7.3.5.4.2 Market size and forecast, by Application
7.3.5.4.3 Market size and forecast, by End User
7.4 Asia-Pacific
7.4.1 Key trends and opportunities
7.4.2 Asia-Pacific Market size and forecast, by Product
7.4.3 Asia-Pacific Market size and forecast, by Application
7.4.4 Asia-Pacific Market size and forecast, by End User
7.4.5 Asia-Pacific Market size and forecast, by country
7.4.5.1 Japan
7.4.5.1.1 Market size and forecast, by Product
7.4.5.1.2 Market size and forecast, by Application
7.4.5.1.3 Market size and forecast, by End User
7.4.5.2 China
7.4.5.2.1 Market size and forecast, by Product
7.4.5.2.2 Market size and forecast, by Application
7.4.5.2.3 Market size and forecast, by End User
7.4.5.3 India
7.4.5.3.1 Market size and forecast, by Product
7.4.5.3.2 Market size and forecast, by Application
7.4.5.3.3 Market size and forecast, by End User
7.4.5.4 Australia
7.4.5.4.1 Market size and forecast, by Product
7.4.5.4.2 Market size and forecast, by Application
7.4.5.4.3 Market size and forecast, by End User
7.4.5.5 Rest of Asia-Pacific
7.4.5.5.1 Market size and forecast, by Product
7.4.5.5.2 Market size and forecast, by Application
7.4.5.5.3 Market size and forecast, by End User
7.5 LAMEA
7.5.1 Key trends and opportunities
7.5.2 LAMEA Market size and forecast, by Product
7.5.3 LAMEA Market size and forecast, by Application
7.5.4 LAMEA Market size and forecast, by End User
7.5.5 LAMEA Market size and forecast, by country
7.5.5.1 Brazil
7.5.5.1.1 Market size and forecast, by Product
7.5.5.1.2 Market size and forecast, by Application
7.5.5.1.3 Market size and forecast, by End User
7.5.5.2 Saudi Arabia
7.5.5.2.1 Market size and forecast, by Product
7.5.5.2.2 Market size and forecast, by Application
7.5.5.2.3 Market size and forecast, by End User
7.5.5.3 South Africa
7.5.5.3.1 Market size and forecast, by Product
7.5.5.3.2 Market size and forecast, by Application
7.5.5.3.3 Market size and forecast, by End User
7.5.5.4 Rest of LAMEA
7.5.5.4.1 Market size and forecast, by Product
7.5.5.4.2 Market size and forecast, by Application
7.5.5.4.3 Market size and forecast, by End User
CHAPTER 8: COMPANY LANDSCAPE
8.1. Introduction
8.2. Top winning strategies
8.3. Product Mapping of Top 10 Player
8.4. Competitive Dashboard
8.5. Competitive Heatmap
8.6. Key developments
CHAPTER 9: COMPANY PROFILES
9.1 3d Biotek LLC
9.1.1 Company overview
9.1.2 Company snapshot
9.1.3 Operating business segments
9.1.4 Product portfolio
9.1.5 Business performance
9.1.6 Key strategic moves and developments
9.2 Advanced Biomatrix, Inc.
9.2.1 Company overview
9.2.2 Company snapshot
9.2.3 Operating business segments
9.2.4 Product portfolio
9.2.5 Business performance
9.2.6 Key strategic moves and developments
9.3 Avantor, Inc.
9.3.1 Company overview
9.3.2 Company snapshot
9.3.3 Operating business segments
9.3.4 Product portfolio
9.3.5 Business performance
9.3.6 Key strategic moves and developments
9.4 Becton, Dickinson And Company
9.4.1 Company overview
9.4.2 Company snapshot
9.4.3 Operating business segments
9.4.4 Product portfolio
9.4.5 Business performance
9.4.6 Key strategic moves and developments
9.5 Corning Incorporated
9.5.1 Company overview
9.5.2 Company snapshot
9.5.3 Operating business segments
9.5.4 Product portfolio
9.5.5 Business performance
9.5.6 Key strategic moves and developments
9.6 Insphero AG
9.6.1 Company overview
9.6.2 Company snapshot
9.6.3 Operating business segments
9.6.4 Product portfolio
9.6.5 Business performance
9.6.6 Key strategic moves and developments
9.7 Lonza Group LTD.
9.7.1 Company overview
9.7.2 Company snapshot
9.7.3 Operating business segments
9.7.4 Product portfolio
9.7.5 Business performance
9.7.6 Key strategic moves and developments
9.8 Merck & Co., Inc.
9.8.1 Company overview
9.8.2 Company snapshot
9.8.3 Operating business segments
9.8.4 Product portfolio
9.8.5 Business performance
9.8.6 Key strategic moves and developments
9.9 Synthecon, Incorporated
9.9.1 Company overview
9.9.2 Company snapshot
9.9.3 Operating business segments
9.9.4 Product portfolio
9.9.5 Business performance
9.9.6 Key strategic moves and developments
9.10 Thermo Fisher Scientific Inc.
9.10.1 Company overview
9.10.2 Company snapshot
9.10.3 Operating business segments
9.10.4 Product portfolio
9.10.5 Business performance
9.10.6 Key strategic moves and developments
TABLE 1. GLOBAL 3D CELL CULTURE MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 2. 3D CELL CULTURE MARKET SIZE, FOR SCAFFOLD BASED PLATFORMS, BY REGION, 2021-2031 ($MILLION)
TABLE 3. 3D CELL CULTURE MARKET FOR SCAFFOLD BASED PLATFORMS, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 4. GLOBAL SCAFFOLD BASED PLATFORMS 3D CELL CULTURE MARKET, BY MACRO-SCALE, 2021-2031 ($MILLION)
TABLE 5. GLOBAL SCAFFOLD BASED PLATFORMS 3D CELL CULTURE MARKET, BY MICRO-SCALE, 2021-2031 ($MILLION)
TABLE 6. GLOBAL SCAFFOLD BASED PLATFORMS 3D CELL CULTURE MARKET, BY NANO-SCALE, 2021-2031 ($MILLION)
TABLE 7. GLOBAL SCAFFOLD BASED PLATFORMS 3D CELL CULTURE MARKET, BY SOLID SCAFFOLDS, 2021-2031 ($MILLION)
TABLE 8. 3D CELL CULTURE MARKET SIZE, FOR SCAFFOLD FREE PLATFORMS, BY REGION, 2021-2031 ($MILLION)
TABLE 9. 3D CELL CULTURE MARKET FOR SCAFFOLD FREE PLATFORMS, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 10. 3D CELL CULTURE MARKET SIZE, FOR GELS, BY REGION, 2021-2031 ($MILLION)
TABLE 11. 3D CELL CULTURE MARKET FOR GELS, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 12. 3D CELL CULTURE MARKET SIZE, FOR BIOREACTORS, BY REGION, 2021-2031 ($MILLION)
TABLE 13. 3D CELL CULTURE MARKET FOR BIOREACTORS, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 14. 3D CELL CULTURE MARKET SIZE, FOR MICROCHIPS, BY REGION, 2021-2031 ($MILLION)
TABLE 15. 3D CELL CULTURE MARKET FOR MICROCHIPS, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 16. 3D CELL CULTURE MARKET SIZE, FOR SERVICES, BY REGION, 2021-2031 ($MILLION)
TABLE 17. 3D CELL CULTURE MARKET FOR SERVICES, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 18. GLOBAL 3D CELL CULTURE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 19. 3D CELL CULTURE MARKET SIZE, FOR CANCER RESEARCH, BY REGION, 2021-2031 ($MILLION)
TABLE 20. 3D CELL CULTURE MARKET FOR CANCER RESEARCH, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 21. 3D CELL CULTURE MARKET SIZE, FOR STEM CELL RESEARCH, BY REGION, 2021-2031 ($MILLION)
TABLE 22. 3D CELL CULTURE MARKET FOR STEM CELL RESEARCH, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 23. 3D CELL CULTURE MARKET SIZE, FOR DRUG DISCOVERY, BY REGION, 2021-2031 ($MILLION)
TABLE 24. 3D CELL CULTURE MARKET FOR DRUG DISCOVERY, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 25. 3D CELL CULTURE MARKET SIZE, FOR REGENERATIVE MEDICINE, BY REGION, 2021-2031 ($MILLION)
TABLE 26. 3D CELL CULTURE MARKET FOR REGENERATIVE MEDICINE, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 27. GLOBAL 3D CELL CULTURE MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 28. 3D CELL CULTURE MARKET SIZE, FOR BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES, BY REGION, 2021-2031 ($MILLION)
TABLE 29. 3D CELL CULTURE MARKET FOR BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 30. 3D CELL CULTURE MARKET SIZE, FOR CONTRACT RESEARCH LABORATORIES, BY REGION, 2021-2031 ($MILLION)
TABLE 31. 3D CELL CULTURE MARKET FOR CONTRACT RESEARCH LABORATORIES, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 32. 3D CELL CULTURE MARKET SIZE, FOR ACADEMIC INSTITUTES, BY REGION, 2021-2031 ($MILLION)
TABLE 33. 3D CELL CULTURE MARKET FOR ACADEMIC INSTITUTES, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 34. 3D CELL CULTURE MARKET, BY REGION, 2021-2031 ($MILLION)
TABLE 35. NORTH AMERICA 3D CELL CULTURE MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 36. NORTH AMERICA 3D CELL CULTURE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 37. NORTH AMERICA 3D CELL CULTURE MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 38. NORTH AMERICA 3D CELL CULTURE MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 39. U.S. 3D CELL CULTURE MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 40. U.S. 3D CELL CULTURE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 41. U.S. 3D CELL CULTURE MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 42. CANADA 3D CELL CULTURE MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 43. CANADA 3D CELL CULTURE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 44. CANADA 3D CELL CULTURE MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 45. MEXICO 3D CELL CULTURE MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 46. MEXICO 3D CELL CULTURE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 47. MEXICO 3D CELL CULTURE MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 48. EUROPE 3D CELL CULTURE MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 49. EUROPE 3D CELL CULTURE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 50. EUROPE 3D CELL CULTURE MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 51. EUROPE 3D CELL CULTURE MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 52. GERMANY 3D CELL CULTURE MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 53. GERMANY 3D CELL CULTURE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 54. GERMANY 3D CELL CULTURE MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 55. FRANCE 3D CELL CULTURE MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 56. FRANCE 3D CELL CULTURE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 57. FRANCE 3D CELL CULTURE MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 58. UK 3D CELL CULTURE MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 59. UK 3D CELL CULTURE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 60. UK 3D CELL CULTURE MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 61. REST OF EUROPE 3D CELL CULTURE MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 62. REST OF EUROPE 3D CELL CULTURE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 63. REST OF EUROPE 3D CELL CULTURE MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 64. ASIA-PACIFIC 3D CELL CULTURE MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 65. ASIA-PACIFIC 3D CELL CULTURE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 66. ASIA-PACIFIC 3D CELL CULTURE MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 67. ASIA-PACIFIC 3D CELL CULTURE MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 68. JAPAN 3D CELL CULTURE MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 69. JAPAN 3D CELL CULTURE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 70. JAPAN 3D CELL CULTURE MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 71. CHINA 3D CELL CULTURE MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 72. CHINA 3D CELL CULTURE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 73. CHINA 3D CELL CULTURE MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 74. INDIA 3D CELL CULTURE MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 75. INDIA 3D CELL CULTURE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 76. INDIA 3D CELL CULTURE MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 77. AUSTRALIA 3D CELL CULTURE MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 78. AUSTRALIA 3D CELL CULTURE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 79. AUSTRALIA 3D CELL CULTURE MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 80. REST OF ASIA-PACIFIC 3D CELL CULTURE MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 81. REST OF ASIA-PACIFIC 3D CELL CULTURE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 82. REST OF ASIA-PACIFIC 3D CELL CULTURE MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 83. LAMEA 3D CELL CULTURE MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 84. LAMEA 3D CELL CULTURE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 85. LAMEA 3D CELL CULTURE MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 86. LAMEA 3D CELL CULTURE MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 87. BRAZIL 3D CELL CULTURE MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 88. BRAZIL 3D CELL CULTURE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 89. BRAZIL 3D CELL CULTURE MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 90. SAUDI ARABIA 3D CELL CULTURE MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 91. SAUDI ARABIA 3D CELL CULTURE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 92. SAUDI ARABIA 3D CELL CULTURE MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 93. SOUTH AFRICA 3D CELL CULTURE MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 94. SOUTH AFRICA 3D CELL CULTURE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 95. SOUTH AFRICA 3D CELL CULTURE MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 96. REST OF LAMEA 3D CELL CULTURE MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 97. REST OF LAMEA 3D CELL CULTURE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 98. REST OF LAMEA 3D CELL CULTURE MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 99.3D BIOTEK LLC: COMPANY SNAPSHOT
TABLE 100.3D BIOTEK LLC: OPERATING SEGMENTS
TABLE 101.3D BIOTEK LLC: PRODUCT PORTFOLIO
TABLE 102.3D BIOTEK LLC: NET SALES,
TABLE 103.3D BIOTEK LLC: KEY STRATERGIES
TABLE 104.ADVANCED BIOMATRIX, INC.: COMPANY SNAPSHOT
TABLE 105.ADVANCED BIOMATRIX, INC.: OPERATING SEGMENTS
TABLE 106.ADVANCED BIOMATRIX, INC.: PRODUCT PORTFOLIO
TABLE 107.ADVANCED BIOMATRIX, INC.: NET SALES,
TABLE 108.ADVANCED BIOMATRIX, INC.: KEY STRATERGIES
TABLE 109.AVANTOR, INC.: COMPANY SNAPSHOT
TABLE 110.AVANTOR, INC.: OPERATING SEGMENTS
TABLE 111.AVANTOR, INC.: PRODUCT PORTFOLIO
TABLE 112.AVANTOR, INC.: NET SALES,
TABLE 113.AVANTOR, INC.: KEY STRATERGIES
TABLE 114.BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT
TABLE 115.BECTON, DICKINSON AND COMPANY: OPERATING SEGMENTS
TABLE 116.BECTON, DICKINSON AND COMPANY: PRODUCT PORTFOLIO
TABLE 117.BECTON, DICKINSON AND COMPANY: NET SALES,
TABLE 118.BECTON, DICKINSON AND COMPANY: KEY STRATERGIES
TABLE 119.CORNING INCORPORATED: COMPANY SNAPSHOT
TABLE 120.CORNING INCORPORATED: OPERATING SEGMENTS
TABLE 121.CORNING INCORPORATED: PRODUCT PORTFOLIO
TABLE 122.CORNING INCORPORATED: NET SALES,
TABLE 123.CORNING INCORPORATED: KEY STRATERGIES
TABLE 124.INSPHERO AG: COMPANY SNAPSHOT
TABLE 125.INSPHERO AG: OPERATING SEGMENTS
TABLE 126.INSPHERO AG: PRODUCT PORTFOLIO
TABLE 127.INSPHERO AG: NET SALES,
TABLE 128.INSPHERO AG: KEY STRATERGIES
TABLE 129.LONZA GROUP LTD.: COMPANY SNAPSHOT
TABLE 130.LONZA GROUP LTD.: OPERATING SEGMENTS
TABLE 131.LONZA GROUP LTD.: PRODUCT PORTFOLIO
TABLE 132.LONZA GROUP LTD.: NET SALES,
TABLE 133.LONZA GROUP LTD.: KEY STRATERGIES
TABLE 134.MERCK & CO., INC.: COMPANY SNAPSHOT
TABLE 135.MERCK & CO., INC.: OPERATING SEGMENTS
TABLE 136.MERCK & CO., INC.: PRODUCT PORTFOLIO
TABLE 137.MERCK & CO., INC.: NET SALES,
TABLE 138.MERCK & CO., INC.: KEY STRATERGIES
TABLE 139.SYNTHECON, INCORPORATED: COMPANY SNAPSHOT
TABLE 140.SYNTHECON, INCORPORATED: OPERATING SEGMENTS
TABLE 141.SYNTHECON, INCORPORATED: PRODUCT PORTFOLIO
TABLE 142.SYNTHECON, INCORPORATED: NET SALES,
TABLE 143.SYNTHECON, INCORPORATED: KEY STRATERGIES
TABLE 144.THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT
TABLE 145.THERMO FISHER SCIENTIFIC INC.: OPERATING SEGMENTS
TABLE 146.THERMO FISHER SCIENTIFIC INC.: PRODUCT PORTFOLIO
TABLE 147.THERMO FISHER SCIENTIFIC INC.: NET SALES,
TABLE 148.THERMO FISHER SCIENTIFIC INC.: KEY STRATERGIES
*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
